This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Nanosys Continues Its Private Affair

Nanosys is working on a lot of potential applications that could find demand once they reach the market: fuel cells for laptops, memory for MP3 players, low-cost solar cells, etc. One of the company's founders, Larry Bock, has a stellar track record of investing in or founding biotech startups such as Ariad Pharmaceuticals, Athena Neurosciences and Neurocrine Biosciences.

"Many of the initial investors got sucked into this as a result of Larry Bock's success in the biotech world and believed that this could be replicated in nanotech," says Harper. "So four years in, they are being asked to pony up again in order to keep the company afloat long enough for them to hit pay dirt somewhere"

Charles Harris, CEO of venture firm Harris and Harris (TINY), which has participated in multiple rounds of private funding for Nanosys, says the nanotech issue is beside the point. First off, investors still labor under the misperception that nanotech is an industry rather than a field of innovation that will affect many industries. Also, Wall Street has been lukewarm toward venture-backed IPOs of all types in the past few years.

"When the Nanosys IPO was pulled, people attributed it to nanotech per se," says Harris, who adds he saw a silver lining in having Nanosys remain private. "It gave us an opportunity to put more money into the company."

What Nanosys' latest round of funding, with a broader array of private funds involved, suggests is that nanotech investment appears to be slowly attracting the interest of private investors. Whether you put the blame on Wall Street or Nanosys, the public markets remain lukewarm to nanotech.

3 of 3

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs